Uterine Filling Pressure in Hysteroscopy
Launched by NORTHWESTERN UNIVERSITY · Sep 14, 2020
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
An a priori sample size calculation was completed. To achieve 80% power and an alpha of .05, the study team needed a sample size of 68 total with 34 participants in each group.The study will be a double-blind randomized control trial. Patients will be recruited based on surgery type (hysteroscopy) and consented using a written consent by the research coordinator with sufficient time to ensure patient comprehension and allow for any questions. The consent process will happen in the pre-operative appointment. Participants will then be randomized to either the standard of care of 80mmHg or the...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients electing for operative or diagnostic hysteroscopy procedures for management of polyps and fibroids
- • Age equal to or greater than 18
- • Ability to understand and willingness to sign consent form. We will include non-English speaking patients in this study
- Exclusion Criteria:
- • Patients electing for operative and diagnostic hysteroscopy procedures with polyps and fibroids
- • Patients under the age of 18
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Magdy P Milad, MD, MM
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials